Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Otago Medical School staff profiles

Professor Michael Schultz

PositionProfessor, Gastroeneterologist, and Head of Department
DepartmentDepartment of Medicine (DSM)
QualificationsMD PhD
Research summaryIntestinal epithelial function in health and disease
Teaching
  • MICN2 and 3: SIS, Systems Integration Course (until 2008)
  • MICN2/3: Clinical advisor in Gastroenterology to the Curriculum Development Group
  • MICN3: Clinical Skills Tutor (since 2008)
  • MICN4: clinical teaching and home tutoring, OSLERs, key topics
  • MICN5: intercalated teaching, OSCE
  • Station development in 2008
  • Lead examiner for 2009
  • MICN6: tutorials for trainee interns
  • MICN5: Mentor, TPER
Clinical

Inflammatory Bowel Disease

Research

Michael Schultz has a special interest in inflammatory bowel diseases and related disorders both on a clinical and basic research level. As director of the Gut Health Network, a research theme of the University of Otago, he is involved in a variety of projects. Basic science: The research group is located in the Department of Physiology in the laboratory of Associate Professor Grant Butt and works on the role of epithelium in intestinal inflammation with the use of human organoids, animal models and cell cultures. Collaborations with the Department of Microbiology and Immunology support these projects. Associate Professor Schultz is involved in several epidemiological and therapeutic projects involving patients with irritable bowel syndrome, coeliac disease, and non-alcoholic fatty liver disease.

Publications

Aluzaite, K., Al-Mandhari, R., Osborne, H., Ho, C., Williams, M., Sullivan, M.-M., Hobbs, C. E., & Schultz, M. (2019). Detailed multi-dimensional assessment of fatigue in inflammatory bowel disease. Inflammatory Intestinal Diseases, 3(4), 192-201. doi: 10.1159/000496054

Johnson, S., Schultz, M., Scholze, M., Smith, T., Woodfield, J., & Hammer, N. (2019). How much force is required to perforate a colon during colonoscopy? An experimental study. Journal of the Mechanical Behavior of Biomedical Materials, 91, 139-148. doi: 10.1016/j.jmbbm.2018.11.024

Khan, A., Boyke Berahmana, A., Day, A. S., Barclay, M. L., & Schultz, M. (2019). New Zealand Society of Gastroenterology guidelines on therapeutic drug monitoring in inflammatory bowel disease. New Zealand Medical Journal, 132(1491), 46-62. Retrieved from https://www.nzma.org.nz/journal

Aluzaite, K., Tewhaiti-Smith, J., Fraser, M., Johnson, S., Glen, E., Beck, A., … Dummer, J., & Schultz, M. (2018). A liver health hui: Hepatitis C knowledge and associated risk factors in New Zealand gang members and their families. Royal Society Open Science, 5, 172167. doi: 10.1098/rsos.172167

Hammer, N., Löffler, S., Cakmak, Y. O., Ondruschka, B., Planitzer, U., Schultz, M., … Weise, D. (2018). Cervical vagus nerve morphometry and vascularity in the context of nerve stimulation: A cadaveric study. Scientific Reports, 8(1), 7997. doi: 10.1038/s41598-018-26135-8

Chapter in Book - Research

Schultz, M., & Burton, J. P. (2017). Escherichia coli Nissle 1917. In M. H. Floch, Y. Ringel & W. A. Walker (Eds.), The microbiota in gastrointestinal pathophysiology: Implications for human health, prebiotics, probiotics, and dysbiosis. (pp. 59-69). Elsevier. doi: 10.1016/B978-0-12-804024-9.00005-7

Burton, J. P., Chanyi, R. M., & Schultz, M. (2017). Common organisms and probiotics: Streptococcus thermophilus (Streptococcus salivarius subsp. thermophilus). In M. H. Floch, Y. Ringel & W. A. Walker (Eds.), The microbiota in gastrointestinal pathophysiology: Implications for human health, prebiotics, probiotics, and dysbiosis. (pp. 165-169). Elsevier. doi: 10.1016/B978-0-12-804024-9.00019-7

Schultz, M., Burton, J. P., & Chanyi, R. M. (2017). Use of Bacillus in human intestinal probiotic applications. In M. H. Floch, Y. Ringel & W. A. Walker (Eds.), The microbiota in gastrointestinal pathophysiology: Implications for human health, prebiotics, probiotics, and dysbiosis. (pp. 119-123). Elsevier. doi: 10.1016/B978-0-12-804024-9.00011-2

Schultz, M. (2008). Escherichia coli. In J. Versalovic & M. Wilson (Eds.), Therapeutic microbiology: Probiotics and related strategies. (pp. 83-96). Washington, DC: ASM Press.

Schultz, M., & Rath, H. C. (2002). The possible role of probiotic therapy in inflammatory bowel disease. In G. W. Tannock (Ed.), Probiotics and prebiotics: Where are we going? (pp. 175-238). Caister Academic Press.

^ Top of page

Journal - Research Article

Aluzaite, K., Al-Mandhari, R., Osborne, H., Ho, C., Williams, M., Sullivan, M.-M., Hobbs, C. E., & Schultz, M. (2019). Detailed multi-dimensional assessment of fatigue in inflammatory bowel disease. Inflammatory Intestinal Diseases, 3(4), 192-201. doi: 10.1159/000496054

Johnson, S., Schultz, M., Scholze, M., Smith, T., Woodfield, J., & Hammer, N. (2019). How much force is required to perforate a colon during colonoscopy? An experimental study. Journal of the Mechanical Behavior of Biomedical Materials, 91, 139-148. doi: 10.1016/j.jmbbm.2018.11.024

Aluzaite, K., Tewhaiti-Smith, J., Fraser, M., Johnson, S., Glen, E., Beck, A., … Dummer, J., & Schultz, M. (2018). A liver health hui: Hepatitis C knowledge and associated risk factors in New Zealand gang members and their families. Royal Society Open Science, 5, 172167. doi: 10.1098/rsos.172167

Hammer, N., Löffler, S., Cakmak, Y. O., Ondruschka, B., Planitzer, U., Schultz, M., … Weise, D. (2018). Cervical vagus nerve morphometry and vascularity in the context of nerve stimulation: A cadaveric study. Scientific Reports, 8(1), 7997. doi: 10.1038/s41598-018-26135-8

Bahi, M., Walmsley, R. S., Gray, A. R., Young, D., Hobbs, C. E., Aluzaite, K., & Schultz, M. (2018). The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines. Journal of Gastroenterology & Hepatology, 33(5), 1047-1052. doi: 10.1111/jgh.14041

Laine, L., Laursen, S. B., Zakko, L., Dalton, H. R., Ngu, J. H., Schultz, M., … Stanley, A. J. (2018). Severity and outcomes of upper gastrointestinal bleeding with bloody vs. coffee-grounds hematemesis. American Journal of Gastroenterology, 113, 358-366. doi: 10.1038/ajg.2018.5

Barclay, M. L., Karim, S., Helms, E. T. J., Keating, P. E., Hock, B., Stamp, L. K., & Schultz, M. (2018). Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays. Internal Medicine Journal. Advance online publication. doi: 10.1111/imj.14064

Coppell, K. J., Galts, C. P.-C., Huizing, F. Y., Norton, J. K., Gray, A. R., Schultz, K., Hobbs, C. E., Aluzaite, K., & Schultz, M. (2018). Annual incidence and phenotypic presentation of IBD in Southern New Zealand: An 18-year epidemiological analysis. Inflammatory Intestinal Diseases, 3(1), 32-39. doi: 10.1159/000492615

Johnson, S., Aluzaite, K., Taar, A., & Schultz, M. (2018). Identifying barriers to treatment of HCV in the primary care setting. Hepatology International. Advance online publication. doi: 10.1007/s12072-018-9902-x

Harvie, R. M., Chisholm, A. W., Bisanz, J. E., Burton, J. P., Herbison, P., Schultz, K., & Schultz, M. (2017). Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World Journal of Gastroenterology, 23(25), 4632-4643. doi: 10.3748/wjg.v23.i25.4632

Schultz, M., Shin, S., & Coppell, K. J. (2017). Awareness of coeliac disease among chefs and cooks depends on the level and place of training. Asia Pacific Journal of Clinical Nutrition, 26(4), 719-724. doi: 10.6133/apjcn.072016.03

Laine, L., Laursen, S. B., Dalton, H. R., Ngu, J. H., Schultz, M., & Stanley, A. J. (2017). Relationship of time to presentation after onset of upper GI bleeding with patient characteristics and outcomes: A prospective study. Gastrointestinal Endoscopy, 86(6), 1026-1037. doi: 10.1016/j.gie.2017.03.1549

Tiong, J., Gray, A., Jackson, C., Thompson-Fawcett, M., & Schultz, M. (2017). Audit of the association between length of time spent on diagnostic work-up and tumour stage in patients with symptomatic colon cancer. ANZ Journal of Surgery, 87(3), 138-142. doi: 10.1111/ans.12804

Stanley, A. J., Laine, L., Dalton, H. R., Ngu, J. H., Schultz, M., Abazi, R., … on behalf of the International Gastrointestinal Bleeding Consortium. (2017). Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: International multicentre prospective study. BMJ, 356, i6432. doi: 10.1136/bmj.i6432

McRae, K. M., Schultz, M., Mackintosh, C. G., Shackell, G. H., Martinez, M. F., Knowler, K. J., … Ho, C., … McEwan, J. C. (2016). Ovine rumen papillae biopsy via oral endoscopy: A rapid and repeatable method for serial sampling. New Zealand Veterinary Journal, 64(3), 174-178. doi: 10.1080/00480169.2015.1121845

McCombie, A., Langlotz, T., Barclay, M., Walmsley, R., Regenbrecht, H., & Schultz, M. (2016). Systematic review of IBD smartphone apps for symptom monitoring and communication with healthcare professionals. Journal of mHealth, 3(3), 36-41. Retrieved from http://www.thejournalofmhealth.com/

Murray, I. A., Joyce, S., Palmer, J., Lau, M., & Schultz, M. (2016). Incidence and features of eosinophilic esophagitis in dysphagia: A prospective observational study. Scandinavian Journal of Gastroenterology, 51(3), 257-262. doi: 10.3109/00365521.2015.1093166

Kwon, H. J., Dudley-Brown, S., Williams, M., Sullivan, M.-M., & Schultz, M. (2016). Validation of a simple, patient directed, symptom based index for intestinal inflammation. Journal of Clinical Gastroenterology & Treatment, 2(2), 020.

Dunn, E. T. J., Taylor, E. S., Stebbings, S., Schultz, M., Butt, A. G., & Kemp, R. A. (2016). Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation. Immunology & Cell Biology, 94(5), 421-429. doi: 10.1038/icb.2015.112

Vermunt, J., Fraser, M., Herbison, P., Wiles, A., Schlup, M., & Schultz, M. (2015). Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand. World Journal of Gastroenterology, 21(35), 10224-10233. doi: 10.3748/wjg.v21.i35.10224

Coppell, K. J., Miller, J. C., Gray, A. R., Schultz, M., Mann, J. I., & Parnell, W. (2015). Obesity and the extent of liver damage among adult New Zealanders: Findings from a national survey. Obesity Science & Practice. doi: 10.1002/osp4.13

Schultz, M., Lai, C. C., Lindstrom, A. L., Stein, K., Donaldson, G., Thompson-Fawcett, M., & Butt, A. G. (2015). Aggravation of established colitis in specific pathogen-free IL-10 knockout mice by restraint stress is not mediated by increased colonic permeability. Journal of Crohn's & Colitis, 9(9), 754-762. doi: 10.1093/ecco-jcc/jjv098

Schultz, M., Bohwan Seo, S., Holt, A., & Regenbrecht, H. (2015). Family history assessment for colorectal cancer (CRC) risk analysis: Comparison of diagram- and questionnaire-based web interfaces. BMC Medical Informatics & Decision Making, 15, 95. doi: 10.1186/s12911-015-0211-1

Johnston, M. R., Murray, I. A., Schultz, M., McLeod, P., O'Donnell, N., Norton, H., … García, J. A. (2015). Does preendoscopy Rockall score safely identify low risk patients following upper gastrointestinal haemorrhage? Gastroenterology Research & Practice, 2015, 410702. doi: 10.1155/2015/410702

Laursen, S. B., Dalton, H. R., Murray, I. A., Michell, N., Johnston, M. R., Schultz, M., … on behalf of the Upper Gastrointestinal Hemorrhage International Consortium. (2015). Performance of new thresholds of the Glasgow Blatchford score in managing patients with upper gastrointestinal bleeding. Clinical Gastroenterology & Hepatology, 13(1), 115-121. doi: 10.1016/j.cgh.2014.07.023

Schultz, H., Higham, J., & Schultz, M. (2014). The informal caregiver: A qualitative assessment of needs and requirements. Family Medicine & Medical Science Research, 3(4), 144. doi: 10.4172/2327-4972.1000144

Dyke, J., Hendry, K., Hill, J., Schultz, M., Mason, E., & Glue, P. (2014). Management of a cluster of foreign body ingestion incidents in patients with borderline personality disorder. Open Journal of Psychiatry, 4, 99-103. doi: 10.4236/ojpsych.2014.42014

Tarr, G. P., Crowley, A., John, R., Kok, J. B., Lee, H.-N. L., Mustafa, H., Sii, K. M., Smith, R., Son, S.-E. Q., Weaver, L. J., Cameron, C., Dockerty, J. D., Schultz, M., & Murray, I. A. (2014). Do high risk patients alter their lifestyle to reduce risk of colorectal cancer? BMC Gastroenterology, 14(1), 22. doi: 10.1186/1471-230X-14-22

Kini, G. P., Schultz, M., Herbison, P., & Young, B. (2014). Does seasonal level of serum 25-OH vitamin D correlate with the activity of Crohn’s disease? New Zealand Medical Journal, 127(1394). Retrieved from http://www.nzma.org.nz/journal

Thomas, G. R., Lewis-Morris, T., Rowbotham, D., Whiteside, C., Joyce, S., Inns, S., Schultz, M., & Gearry, R. B. (2014). Adalimumab for Crohn’s disease in New Zealand: A prospective multicentre experience. New Zealand Medical Journal, 127(1396). Retrieved from http://www.nzma.org.nz/journal

Schultz, M., Dunn, E., Taylor, E., Butt, G. A., & Kemp, R. (2013). The Gut Map Project: T cell distribution in inflammation of the gut. Journal of Gastroenterology & Hepatology, 28(Suppl. 3), 588. doi: 10.1111/jgh.12363_2

Kini, G. P., Murray, I., Champion-Young, J., Lau, M., Katta, V., Thorn, M., & Schultz, M. P. (2013). Cap polyposis mistaken for Crohn's disease: Case report and review of literature. Journal of Crohn's & Colitis, 7(3), e108-e111. doi: 10.1016/j.crohns.2012.06.005

Tarr, G. P., Smith, R. A., John, R. A., Crowley, A. P., Kok, J. B. C., Lee, H.-N., Mustafa, M. H. B., Sii, K. M., Son, S.-E., Weaver, L. J., Cameron, C., Dockerty, J. D., Murray, I. A., & Schultz, M. (2013). Perceived risks and benefits of surveillance colonoscopy in people undergoing surveillance for family history of colorectal cancer. New Zealand Medical Journal, 126(1382). Retrieved from http://www.nzma.org.nz/journal

Kemp, R., Dunn, E., & Schultz, M. (2013). Immunomodulators in inflammatory bowel disease: An emerging role for biologic agents. BioDrugs, 27(6), 585-590. doi: 10.1007/s40259-013-0045-2

Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., … for the GEMINI 2 Study Group, including Gearry, R., Schultz, M., & Wyeth, J. (2013). Vedolizumab as induction and maintenance therapy for Crohn's disease. New England Journal of Medicine, 369(8), 711-721. doi: 10.1056/NEJMoa1215739

Stebbings, S., Jenks, K., Treharne, G. J., García, J. A., Schultz, M., Highton, J., & Dudley-Brown, S. (2012). Validation of the Dudley Inflammatory Bowel Symptom Questionnaire for the assessment of bowel symptoms in axial SpA: Prevalence of clinically relevant bowel symptoms and association with disease activity. Rheumatology, 51(5), 858-865. doi: 10.1093/rheumatology/ker359

Pan, A., Schlup, M., Lubcke, R., Chou, A., & Schultz, M. (2012). The role of aspirin in post-polypectomy bleeding: A retrospective survey. BMC Gastroenterology, 12, 138. doi: 10.1186/1471-230X-12-138

Tannock, G. W., Tiong, I. S., Priest, P., Munro, K., Taylor, C., Richardson, A., & Schultz, M. (2011). Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities. Journal of Medical Microbiology, 60(3), 366-370. doi: 10.1099/jmm.0.025874-0

Pan, A., Schlup, M., Lubcke, R., & Schultz, M. (2011). Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: A case report and literature review. Journal of Crohn's & Colitis, 5(5), 465-468. doi: 10.1016/j.crohns.2011.04.011

Schultz, M., Baranchi, A., Thurston, L., Yu, Y. C., Wang, L., Chen, J., Sapsford, M., Chung, J., Binsadiq, M., Craig, L., Wilkins, B., McBride, D., & Herbison, P. (2011). Consumer demographics and expectations of probiotic therapy in New Zealand: Results of a large telephone survey. New Zealand Medical Journal, 124(1329). Retrieved from http://journal.nzma.org.nz/journal/124-1329/4537/content.pdf

Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P., & Highton, J. (2010). Probiotic therapy for the treatment of spondyloarthritis: A randomized controlled trial. Journal of Rheumatology, 37(10), 2118-2125. doi: 10.3899/jrheum.100193

Schultz, M., & Butt, G. (2010). E. coli Nissle 1917 in the treatment of inflammatory bowel disease. Practical Gastroenterology, 34(3), 11-19.

Stebbings, S., Jenks, K., Roberts, R., & Schultz, M. (2010). The immune response to gut bacteria in spondyloarthritis: A role in pathogenesis? Journal of Clinical Rheumatology & Musculoskeletal Medicine, 1(2).

Schultz, M., Gearry, R., Walmsley, R., Day, A. S., Fraser, A., Wyeth, J., Barclay, M., … Whiteside, C. (2010). New Zealand Society of Gastroenterology statement on the use of biological therapy in inflammatory bowel disease. New Zealand Medical Journal, 123(1314). Retrieved from http://journal.nzma.org.nz/journal/123-1314/4115/content.pdf

Schultz, M., Davidson, A., Donald, S., Targonska, B., Turnbull, A., Weggery, S. E., Livingstone, V., & Dockerty, J. D. (2009). Gastroenterology service in a teaching hospital in rural New Zealand, 1991-2003. World Journal of Gastroenterology, 15(5), 583-590. doi: 10.3748/wjg.15.583

Switzer-Taylor, V., Schlup, M., Lübcke, R., Livingstone, V., & Schultz, M. (2008). Barrett's esophagus: A retrospective analysis of 13 years surveillance. Journal of Gastroenterology & Hepatology, 23(9), 1362-1367.

Howard, R., Karageorge, G., van Harselaar, K., Bell, M., Basford, P., Schultz, M., & Derrett, S. (2008). Post-procedure surveillance in liver biopsy: How long is long enough? New Zealand Medical Journal, 121(1280). Retrieved from http://journal.nzma.org.nz/journal/121-1280/3219/content.pdf

Schultz, M., & Lindström, A. L. (2008). Rationale for probiotic treatment strategies in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology, 2(3), 337-355. doi: 10.1586/17474124.2.3.337

Schultz, M. (2008). Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflammatory Bowel Diseases, 14(7), 1012-1018.

Schultz, M., & Butt, A. G. (2007). Methodological aspects in probiotic research: A brief review with an emphasis on epithelial barrier function. International Journal of Probiotics & Prebiotics, 2(2/3), 85-96.

McBurney, W., Mangold, M., Munro, K., Schultz, M., Rath, H. C., & Tannock, G. W. (2006). PCR/DGGE and 16S rRNA gene library analysis of the colonic microbiota of HLA-B27/β2-microglobulin transgenic rats. Letters in Applied Microbiology, 42, 165-171.

Strauch, U. G., Obermeier, F., Grunwald, N., Gürster, S., Dunger, N., Schultz, M., … Rath, H. C. (2005). Influence of intestinal bacteria on induction of regulatory T cells: Lessons from a transfer model of colitis. Gut, 54, 1546-1552. Retrieved from http://gut.bmjjournals.com

Schultz, M., Watzl, S., Oelschlaeger, T. A., Rath, H. C., Göttl, C., Lehn, N., … Linde, H.-J. (2005). Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo. Journal of Microbiological Methods, 61, 389-398.

Schultz, M. (2005). Celiac disease: More common than previously assumed. AESKU.SCIENCE, 2(October), 3-9.

Schultz, M., Schölmerich, J., & Kullmann, F. (2004). Management of chemotherapy-induced diarrhea. Zeitschrift für Gastroenterologie, 42(6), 527-538.

Schultz, M., Munro, K., Tannock, G. W., Melchner, I., Göttl, C., Schwietz, H., … Rath, H. C. (2004). Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clinical & Diagnostic Laboratory Immunology, 11(3), 581-587.

Schultz, M., Göttl, C., Young, R. J., Iwen, P., & Vanderhoof, J. A. (2004). Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. Journal of Pediatric Gastroenterology & Nutrition, 38(3), 293-297.

Schultz, M., Timmer, A., Herfarth, H. H., Sartor, R. B., Vanderhoof, J. A., & Rath, H. C. (2004). Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterology, 4(5). Retrieved from http://www.biomedcentral.com/content/pdf/1471-230X/4/5.pdf

Gerbitz, A., Schultz, M., Wilke, A., Linde, H.-J., Schölmerich, J., Andreesen, R., & Holler, E. (2004). Probiotic effects on experimental graft-versus-host disease: Let them eat yogurt. Blood, 103(11), 4365-4367.

Schultz, M., Strauch, U. G., Linde, H.-J., Watzl, S., Obermeier, F., Göttl, C., … Rath, H. C. (2004). Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clinical & Diagnostic Laboratory Immunology, 11(2), 372-378.

von Landenberg, P., Matthias, T., Zaech, J., Schultz, M., Lorber, M., Blank, M., & Shoenfeld, Y. (2003). Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. American Journal of Reproductive Immunology, 49, 51-56.

Schultz, M., Schölmerich, J., & Rath, H. C. (2003). Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Digestive Diseases, 21(2), 105-128.

Schultz, M., Linde, H.-J., Lehn, N., Zimmermann, K., Grossmann, J., Falk, W., & Schölmerich, J. (2003). Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. Journal of Dairy Research, 70(2), 165-173.

Grossmann, J., Walther, K., Artinger, M., Kiessling, S., Steinkamp, M., Schmautz, W.-K., … Schultz, M., … Rogler, G. (2003). Progress on isolation and short-term ex-vivo culture of highly purified non-apoptotic human intestinal epithelial cells (IEC). European Journal of Cell Biology, 82, 262-270.

Schultz, M., & Hellerbrand, C. (2002). Viele Fälle bleiben unerkannt. Deutsches Ärzteblatt, 99, 28-29.

Schultz, M., Hartmann, A., Dietmaier, W., Woenckhaus, M., & Lock, G. (2002). Massive steatosis hepatis: An unusual manifestation of Whipple's disease. American Journal of Gastroenterology, 97(3), 771-772.

Schultz, M., Veltkamp, C., Dieleman, L. A., Grenther, W. B., Wyrick, P. B., Tonkonogy, S. L., & Sartor, R. B. (2002). Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflammatory Bowel Diseases, 8(2), 71-80.

Schultz, M., Clarke, S. H., Arnold, L. W., & Sartor, R. B. (2001). Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology, 104(2), 127-134.

Rath, H. C., Schultz, M., Freitag, R., Dieleman, L. A., Li, F., Linde, H.-J., … Sartor, R. B. (2001). Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infection & Immunity, 69(4), 2277-2285.

^ Top of page

Journal - Research Other

Khan, A., Boyke Berahmana, A., Day, A. S., Barclay, M. L., & Schultz, M. (2019). New Zealand Society of Gastroenterology guidelines on therapeutic drug monitoring in inflammatory bowel disease. New Zealand Medical Journal, 132(1491), 46-62. Retrieved from https://www.nzma.org.nz/journal

Harvie, R., Chanyi, R. M., Burton, J. P., & Schultz, M. (2017). Using the human gastrointestinal microbiome to personalize nutrition advice: Are registered dietitian nutritionists ready for the opportunities and challenges? Journal of the Academy of Nutrition & Dietetics, 117(12), 1865-1869. doi: 10.1016/j.jand.2016.10.020

Harvie, R., Walmsley, R., Schultz, M., on behalf of the New Zealand Society of Gastroenterology. (2017). “We are what our bacteria eat”: The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions. Journal of Gastroenterology & Hepatology, 32(2), 352-357. doi: 10.1111/jgh.13462

Hendry, K., Glue, P., Hill, J., & Schultz, M. (2015). Ingestion of sharp foreign objects: A case series, literature review and management recommendation [Case review]. Journal of Gastric Disorders & Therapy, 1(1). doi: 10.16966/jgdt.101

Kini, G. P., McAlindon, M. E., Schultz, M., Collett, J., & Murray, I. A. (2013). Gastrointestinal: Capsule endoscopy of a very refractory celiac disease. Journal of Gastroenterology & Hepatology, 28(8), 1254. doi: 10.1111/jgh.12298

Coffey, S., Nadarasa, K., Pan, A., van der Linden, A., Chu, J., & Schultz, M. (2012). The increasing incidence of Streptococcus bovis endocarditis and bacteraemia: A case series from 1997 to 2010. International Journal of Cardiology, 161(2), 111-113. doi: 10.1016/j.ijcard.2012.06.031

Schultz, M., & Butt, A. G. (2012). Is the north to south gradient in inflammatory bowel disease a global phenomenon? Expert Review of Gastroenterology & Hepatology, 6(4), 445-447. doi: 10.1586/egh.12.31

Pan, A., Doyle, T., Schlup, M., Lubcke, R., & Schultz, M. (2011). Unusual manifestation of Erdheim-Chester disease. BMC Gastroenterology, 11, 77. doi: 10.1186/1471-230x-11-77

Schultz, M., Roberts, R. L., & Butt, A. G. (2010). Understanding probiotic treatment strategies in inflammatory bowel disease, with a special emphasis on the intestinal barrier. European Gastroenterology & Hepatology Review, 6(1), 58-65.

More publications...